<i>In Vitro</i> Activities and Inoculum Effects of Ceftazidime-Avibactam and Aztreonam-Avibactam against Carbapenem-Resistant <i>Enterobacterales</i> Isolates from South Korea

<i>In Vitro</i> Activities and Inoculum Effects of Ceftazidime-Avibactam and Aztreonam-Avibactam against Carbapenem-Resistant <i>Enterobacterales</i> Isolates from South Korea

Ceftazidime-avibactam (CAZ-AVI) and aztreonam-avibactam (AZT-AVI) are novel antibiotic combinations active against multidrug-resistant Gram-negative pathogens. This study aimed to evaluate their in vitro activities and inoculum effects in carbapenem-resistant <i>Enterobacterales</i> (CRE...

Full description

Bibliographic Details
Main Authors:	Taeeun Kim, Seung Cheol Lee, Moonsuk Bae, Heungsup Sung, Mi-Na Kim, Jiwon Jung, Min Jae Kim, Sung-Han Kim, Sang-Oh Lee, Sang-Ho Choi, Yang Soo Kim, Yong Pil Chong
Format:	Article
Language:	English
Published:	MDPI AG 2020-12-01
Series:	Antibiotics
Subjects:	carbapenem-resistant <i>Enterobacterales</i> ceftazidime-avibactam aztreonam-avibactam inoculum effect susceptibility
Online Access:	https://www.mdpi.com/2079-6382/9/12/912

Similar Items

In vitro efficacy of ceftazidime-avibactam, aztreonam-avibactam and other rescue antibiotics against carbapenem-resistant Enterobacterales from the Arabian Peninsula
by: Ágnes Sonnevend, et al.
Published: (2020-10-01)

The Revival of Aztreonam in Combination with Avibactam against Metallo-β-Lactamase-Producing Gram-Negatives: A Systematic Review of In Vitro Studies and Clinical Cases
by: Carola Mauri, et al.
Published: (2021-08-01)

Avibactam potentiated the activity of both ceftazidime and aztreonam against S. maltophilia clinical isolates in vitro
by: Qiuxia Lin, et al.
Published: (2021-02-01)

In vitro Activity of Ceftazidime-Avibactam and Aztreonam-Avibactam Against Carbapenem-resistant Enterobacteriaceae Isolates Collected from Three Secondary Hospitals in Southwest China Between 2018 and 2019
by: Zou C, et al.
Published: (2020-10-01)

Antimicrobal resistance of nosocomial carbapenemase-producing Enterobacterales in Russia: results of surveillance, 2014-2016
by: Shajdullina E.R., et al.
Published: (2018-11-01)

Molecular characterization of clinical isolates of Enterobacterales with elevated MIC values for aztreonam-avibactam from the INFORM global surveillance study, 2012–2017
by: Mark Estabrook, et al.
Published: (2021-03-01)

Genetic diversity and in vitro activity of ceftazidime/avibactam and aztreonam/avibactam against imipenem-resistant Enterobacteriaceae isolates in Southwest China: A single-centre study
by: Jie Wei, et al.
Published: (2020-09-01)

Combination of aztreonam, ceftazidime–avibactam and amikacin in the treatment of VIM-1 Pseudomonas aeruginosa ST235 osteomyelitis
by: Alessandra Mularoni, et al.
Published: (2021-07-01)

Aztreonam plus ceftazidime-avibactam as treatment of NDM-1-producing Klebsiella pneumoniae bacteraemia in a neutropenic patient: Last resort therapy?
by: Paola Bocanegra-Ibarias, et al.
Published: (2020-12-01)

CP-CRE/non-CP-CRE Stratification And CRE Resistance Mechanism Determination Help In Better Managing CRE Bacteremia Using Ceftazidime–Avibactam And Aztreonam–Avibactam
by: Zou H, et al.
Published: (2019-09-01)

Therapeutic Options for Metallo-β-Lactamase-Producing Enterobacterales
by: Tan X, et al.
Published: (2021-01-01)

In vitro and in vivo bactericidal activity of ceftazidime-avibactam against Carbapenemase–producing Klebsiella pneumoniae
by: Wenxia Zhang, et al.
Published: (2018-11-01)

Therapeutic Options for Metallo-β-Lactamase-Producing Enterobacterales [Corrigendum]
by: Tan X, et al.
Published: (2021-02-01)

Resistance to ceftazidime/avibactam in infections and colonisations by KPC-producing Enterobacterales: a systematic review of observational clinical studies
by: Stefano Di Bella, et al.
Published: (2021-06-01)

In vitro activity of ceftazidime/avibactam against ceftazidime-resistant Enterobacterales and Pseudomonas aeruginosa from hospitalised patients in Germany
by: Michael Kresken, et al.
Published: (2021-06-01)

Successful Treatment of <i>Klebsiella pneumoniae</i> NDM Sepsis and Intestinal Decolonization with Ceftazidime/Avibactam Plus Aztreonam Combination in a Patient with TTP Complicated by SARSCoV-2 Nosocomial Infection
by: Francesco Perrotta, et al.
Published: (2021-04-01)

In vitro antimicrobial susceptibility of clinical respiratory isolates to ceftazidime-avibactam and comparators (2016–2018)
by: D. Piérard, et al.
Published: (2021-06-01)

Clinical Experience with Ceftazidime-Avibactam for the Treatment of Infections due to Multidrug-Resistant Gram-Negative Bacteria Other than Carbapenem-Resistant <em>Enterobacterales</em>
by: Antonio Vena, et al.
Published: (2020-02-01)

Evaluation of the Etest and disk diffusion method for detection of the activity of ceftazidime-avibactam against Enterobacterales and Pseudomonas aeruginosa in China
by: Qi Wang, et al.
Published: (2020-06-01)

Ceftolozane/Tazobactam and Ceftazidime/Avibactam for Multidrug-Resistant Gram-Negative Infections in Immunocompetent Patients: A Single-Center Retrospective Study
by: Rosario Cultrera, et al.
Published: (2020-09-01)

Efficacy of ceftazidime-avibactam in the treatment of infections due to Carbapenem-resistant Enterobacteriaceae
by: Basem M. Alraddadi, et al.
Published: (2019-09-01)

Ceftazidime-avibactam in the treatment of infections from carbapenem-resistant Klebsiella pneumoniae
by: Jie Gu, et al.
Published: (2021-09-01)

Resistance to ceftazidime–avibactam and underlying mechanisms
by: Yuhang Wang, et al.
Published: (2020-09-01)

Effectiveness of ceftazidime–avibactam versus colistin in treating carbapenem-resistant Enterobacteriaceae bacteremia
by: Hakeam A. Hakeam, et al.
Published: (2021-08-01)

Reduced Ceftazidime-Avibactam Susceptibility in KPC-Producing Klebsiella pneumoniae From Patients Without Ceftazidime-Avibactam Use History – A Multicenter Study in China
by: Xiaoyan Cui, et al.
Published: (2020-06-01)

Optimal Management of Complicated Infections in the Pediatric Patient: The Role and Utility of Ceftazidime/Avibactam
by: Bassetti M, et al.
Published: (2020-06-01)

Molecular and phenotypical characterization of two cases of antibiotic-driven ceftazidime-avibactam resistance in blaKPC-3-harboring Klebsiella pneumoniae
by: Venditti C, et al.
Published: (2019-07-01)

In vitro activity of aztreonam–avibactam against metallo-β-lactamase-producing Enterobacteriaceae—A multicenter study in China
by: Biying Zhang, et al.
Published: (2020-08-01)

In vitro activity of aztreonam/avibactam against a global collection of Klebsiella pneumoniae collected from defined culture sources in 2016 and 2017
by: S. Esposito, et al.
Published: (2021-03-01)

Review of Ceftazidime-Avibactam for the Treatment of Infections Caused by <i>Pseudomonas aeruginosa</i>
by: George L. Daikos, et al.
Published: (2021-09-01)

Antimicrobial susceptibility testing of Enterobacteriaceae: determination of disk content and Kirby-Bauer breakpoint for ceftazidime/avibactam
by: Xianggui Yang, et al.
Published: (2019-11-01)

Emergence of Hypervirulent Ceftazidime/Avibactam-Resistant Klebsiella pneumoniae Isolates in a Chinese Tertiary Hospital
by: Li D, et al.
Published: (2020-08-01)

Global trends of antimicrobial susceptibility to ceftaroline and ceftazidime–avibactam: a surveillance study from the ATLAS program (2012–2016)
by: Hui Zhang, et al.
Published: (2020-10-01)

Clinical efficacy of ceftazidime/avibactam versus other active agents for the treatment of bacteremia due to carbapenemase-producing Enterobacteriaceae in hematologic patients
by: Juan J. Castón, et al.
Published: (2017-06-01)

In vitro antibacterial activity of ceftazidime/avibactam in combination against planktonic and biofilm carbapenemase-producing Klebsiella pneumoniae isolated from blood
by: Chiara Papalini, et al.
Published: (2020-12-01)

In vitro Optimization of Ceftazidime/Avibactam for KPC-Producing Klebsiella pneumoniae
by: Yanqin Huang, et al.
Published: (2021-03-01)

Use of carbapenems in the combined treatment of emerging ceftazidime/avibactam-resistant and carbapenem-susceptible KPC-producing Klebsiella pneumoniae infections: Report of a case and review of the literature
by: Ángela Cano, et al.
Published: (2020-09-01)

Native mitral valve endocarditis associated with KPC producing Serratia marcescens bacteremia successfully treated with mitral valve replacement and ceftazidime-avibactam
by: Alwin Tilanus, et al.
Published: (2021-01-01)

Carbapenemase detection testing in the era of ceftazidime/avibactam-resistant KPC-producing Enterobacterales: A 2-year experience
by: Gabriele Bianco, et al.
Published: (2021-03-01)

Ceftazidime-avibactam: new rules for the game against multidrug-resistant gram-negative bacteria
by: Kozlov R.S., et al.
Published: (2018-02-01)

Cannot write session to /tmp/vufind_sessions/sess_fednfagdc94iv7dfhqji4kvk26